John E. Trusheim

John E. Trusheim

Neurology
3601 Minnesota Dr
Suite 200
Bloomington, MN 55435

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications

Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort Trial.

Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort Trial.

Journal: JAMA oncology
Published: November 17, 2022

Correction to: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.

Correction to: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.

Journal: Journal of translational medicine
Published: June 08, 2018

First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.

First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.

Journal: Journal of translational medicine
Published: April 27, 2018

Carboplatin-associated Cranial Neuropathy.

Carboplatin-associated Cranial Neuropathy.

Journal: Neuro-ophthalmology (Aeolus Press)
Published: November 06, 2017

A state-of-the-art review and guidelines for tumor treating fields treatment planning and patient follow-up in glioblastoma.

A state-of-the-art review and guidelines for tumor treating fields treatment planning and patient follow-up in glioblastoma.

Journal: CNS oncology
Published: September 16, 2016
Showing 1-5 of 5

Last Updated: 09/26/2026